Managed Healthcare Executive58m
Trial Supports Bizengri as a Promising Treatment for NRG1 Fusion-Positive Cancers, Including Advanced Lung Cancer
A new study validates NRG1 gene fusions as a targetable driver of advanced NRG1 fusion-positive cancers, adding support for ...